Novel adoptive transfer mouse models in CLL
Elisa ten Hacken
Can we apply knowledge on CLL to other types of cancers?
Matched unrelated donor (MUD) transplantations for ALL and AML
Safety issues with CAR T-cell therapy for acute lymphocytic leukemia
The importance of considering a CLL patient's tumor lysis risk status